Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 275308
Mavacamten and MYK-224 is currently being tested in the pivotal, Phase 3 EXPLORER-HCM clinical trial for the treatment of symptomatic, obstructive HCM. HCM is the most common form of genetic heart disease. It is a chronic, progressive condition estimated to affect one in every 500 people worldwide and is characterized by the thickening of the heart walls due to excessive contraction. EXPLORER-HCM is a multi-national, randomized, double-blind study that will enroll more than 220 patients. Patients will be randomized 11 to receive mavacamten or placebo for 30 weeks with a primary endpoint of clinical response designed to assess improvements in patient symptoms and function.
IPSCIO Record ID: 359108
Cannabidiol is a non-psychoactive molecule with broad therapeutic potential in the treatment of chronic inflammatory disease including heart failure.
Field of use to treat cardiovascular disease, cardiopulmonary disease, and cardiac arrhythmias.
IPSCIO Record ID: 240469
The licensed property is Angiotensin-converting enzyme genetic variant screens; Transgenic model and treatment for heart disease; Transgenic Model for Heart Failure; Method for identifying adrenergic receptor antagonists having good tolerability; Diagnosis and treatment of myocardial failure; Method of treating heart failure; Inhibition of HDAC as a treatment for cardiac hypertrophy; and, Quantitative analysis of closely related protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry.